From left: Dr. Brianna McKelvie, Paediatric Intensive Care Physician at Children’s Hospital at London Health Sciences Centre (LHSC); Saoirse Cameron, Lawson Research Coordinator; Dr. Sepideh Taheri, Lawson Associate Scientist and Paediatrician at Children’s Hospital at LHSC; Dr. Dirk Bock, Lawson Associate Scientist and Paediatrician at Children’s Hospital at LHSC; and Dr. Frances Yeung, Paediatric Resident at Children’s Hospital at LHSC and Schulich School of Medicine & Dentistry, Western University.
Children admitted to hospital often require medications delivered directly to their blood stream. This is normally achieved through the insertion of a peripheral intravenous catheter (PIVC). A PIVC is a small plastic tube that is inserted into a person’s vein and left there for the delivery of medication or hydrating fluids.
Researchers Rachel Brown and Dr. Jamie Seabrook, studied health data from 25,000 pregnant women and have shown that depression is the largest driver of substance use during pregnancy.
It is well known that tobacco, alcohol, and cannabis use during pregnancy are associated with poor birth outcomes, yet many women continue to use these substances during pregnancy.
Researchers at Western University and its affiliate Brescia University College have now shown that depression is the single largest driver of substance use during pregnancy, highlighting the need for greater supports for the mental health of pregnant mothers.